IMM 0.00% 28.5¢ immutep limited

a lot of stuff, page-32

  1. 563 Posts.
    lightbulb Created with Sketch. 141
    Bioler, Novegen's Phenoxodial trials have been halted - however that's not to say the drug is no use - I think it's being superceded by a the widely acting NV-128. An announcement came out yesterday worth reading... some further interpreation of the results. I think though Phenoxodial has been superceded by NV-128, which is an chemically similar (an anolog). NV-128 appears to inhibit cancer stem cells of many types of cancers... the info isn't clear or simple.

    My guess is NV-128 could be a big winner, has superceded Phenoxodial, and could possibly have the same results for patients as cVac *might*. I see a small-medium risk here!!
    NOTE: I am not a scientest, researcher, or otherwise! Gamble how you wish!

    Bottom line though, Novogen are a company to watch. I'm holding them and increasing exporuse.
    Unfortunately they aren't pennies ;)

    I'm open to corrections!
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
28.5¢
Change
0.000(0.00%)
Mkt cap ! $414.5M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 60000 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 717985 2
View Market Depth
Last trade - 09.28am 01/11/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.